Working... Menu

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02600429
Recruitment Status : Recruiting
First Posted : November 9, 2015
Last Update Posted : March 5, 2019
Information provided by (Responsible Party):
ReGenTree, LLC

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 2019
  Estimated Study Completion Date : August 2019